SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ONXX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Hua who wrote (397)8/2/2000 5:44:05 PM
From: Elmer  Read Replies (1) of 810
 
<I doubt there were too many true investors buying at these inflated levels.>
I guess that's the real question. The publicity may have brought real investors into the stock. I'm hanging in regardless of the stock's moves for one simple reason. The rewards are tremendous if the drug is successful in Phase III trials. If you want to see what I mean, pull a five year chart on Medimmune (MEDI) and IDEC (IDPH). They went up an order of magnitude or more from the successful completion and commercialization of drugs with smaller patient markets.

I hope you can cover this week and make a profit. But long-term this is the last stock I would short, if only because a couple institutions could come in and knock out 50% of the float and double the price.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News